Nabil Saba, MD, FACP
-
RoleMedical Oncology
-
Research Program
-
Practicing Since1999
![Nabil F. Saba, MD, FACP](_images/saba-n-headshot.jpg)
Rating: 4.6 out of 5 (220 ratings)
Nabil F. Saba, MD, FACP, is an internationally recognized expert in the treatment of head and neck cancers. Dr. Saba is professor and vice chair in the Department of Hematology and Medical Oncology, and the Inaugural Lynne and Howard Halpern Chair in Head and Neck Cancer Research. He holds a joint appointment as professor in the Department of Otolaryngology at Emory University School of Medicine. He serves as director of the Head and Neck Cancer Medical Oncology Program and is co-leader of the Multidisciplinary Head and Neck Program at Winship Cancer Institute of Emory University.
Dr. Saba is a well-recognized expert in immunotherapy for head and neck cancer and upper aero-digestive malignancies. His work is focused on translational research and the study and development of novel therapeutic agents and modalities in these diseases. He has been principal investigator in more than 50 clinical trials and chairs national as well as investigator initiated multi-institution studies focusing on novel approaches for treating head and neck and esophageal cancer. Dr Saba has been instrumental in establishing the head and neck cancer research working group at Winship Cancer Institute and is the contact principal investigator of the Lead Academic Participating Site (LAPS) grant of the NCI’s National Clinical Trials Network (NCTN).
Dr. Saba has been elected for two terms as chair and chair emeritus of the National Cancer Institute's task force for recurrent metastatic head and neck cancer, and chaired the Rare Tumors Task Force of the National Cancer Institute's Head and Neck Cancer Steering Committee. He is an active member of the NRG Oncology and Eastern Cooperative Oncology Group Head and Neck Cancer Core Committees, and chairs two NCI cooperative group trials in the field of head and neck oncology under the ECOG-ACRIN group. Dr Saba has received competitive NIH funding investigating novel genomic approaches in HPV related and unrelated OPCA and is the recipient of intramural funding studying this disease. He has published more than 290 peer reviewed manuscripts and textbook chapters and is editor of two textbooks : “Esophageal Cancer: Prevention, Diagnosis and Therapy” published in two editions and “Sino-Nasal and Skull Base Malignancies”. He is associate editor of JNCI, and Head Neck and served as a member of the ASCO Guidelines Committee.
Dr. Saba earned his Medical Degree from the American University of Beirut Medical School. He completed a Residency in Internal Medicine at Tufts University School of Medicine in Boston, and a Clinical Fellowship in Hematology and Oncology at Brown University School of Medicine. He subsequently completed a Bone Marrow Transplant Fellowship at the University of Toronto Princess Margaret Hospital in Toronto, Canada.
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
4.7 |
| Provider showed concern |
4.6 |
| Provider explained things clearly |
4.6 |
| Provider discussed treatment options |
4.6 |
| Provider included you in decisions |
4.6 |
| Likelihood of recommending this provider |
|
06/20/2024 |
It was all good news. |
|
06/18/2024 |
It was a good initial visit. |
|
06/15/2024 |
It was just a lot to take in, but we understood the Doctor was saying overall about the treatment and hopefully the out come . |
|
05/02/2024 |
Dr'did not offer any specific info for patient with critical cancer. Did not answer all questions and stated I would be called to set up appt next week. Was not called and happened to see appt on My Chart. Appt was not set for the next week as stated but the following week. |
|
05/01/2024 |
Seems like members of the team didn't know what each other was doing |
|
04/09/2024 |
Bad |
|
04/04/2024 |
Had an excellent report |
|
02/21/2024 |
No bad experience. |
|
01/11/2024 |
As always Dr Saba is up front about my cancer. |
|
12/09/2023 |
Really liked Dr Saba |
|
12/06/2023 |
I felt relief from some worries I was having. |
|
11/17/2023 |
I was given great news. |
|
11/14/2023 |
Good |
|
11/02/2023 |
Good |
|
10/31/2023 |
Doc. Saba was very much in sync with my prognosis. I understand the plan of action. |
|
10/07/2023 |
Dr Saba very good- would like to see him at every appt |
|
09/28/2023 |
They gave me a great consultation |
|
09/22/2023 |
Dr. Saba is exceptional. I would travel great distances and go to great personal inconvenience to be able to receive the care he provides. |
|
09/12/2023 |
I wouldn't care to go anywhere else but Emory. |
|
08/26/2023 |
Excellent Dr Saba is a Great Professional Doctor |
|
06/22/2023 |
Very good information/instructions from Dr. Saba. I felt better after seeing the Doctor. |
|
06/22/2023 |
Dr. Saba is an awesome doctor, very helpful, kind & friendly. |
|
05/04/2023 |
Dr. Saba is a rare mix of extensive medical knowledge, experience, and a caring person. We respect him but also like him a lot too. We also feel this way about Annette. |
|
03/29/2023 |
Dr. Saba is very professional but also personal as well. |
|
03/01/2023 |
Doctor Saba is informative and instills confidence. I feel I can trust his judgement and that he listens to my opinion and concerns. |
|
02/04/2023 |
Dr. Saba explained that he believes the treatments are working for me. He also relieved my mind by letting me know that the small spot they see is nothing of concern! It's too small to tell what it as It's apparent there Is no change. They have been seeing it on several scans but I'm confident in Dr. Saba's assessment. |
|
12/15/2022 |
Excellent communication |
|
11/11/2022 |
Dr Saba instills confidence and expertise related to my care. I'm more comfortable at Dr Sabas office rather than the clinical trial dept. ( I was there a year. I wish I could have had clinical trial in Saba's office. ) until very recently there was no Doctor doing patient care/oversight in clinical trial phase 1 dept. |
|
09/29/2022 |
I met with a team at the head and neck clinic.Everyone did an excellent job of explaining options |
|
09/10/2022 |
Very Good. |